FY2025 · ended Dec 31, 2025 · Revenue $5.93B, -2.1% YoY · Filed Feb 25, 2026
agilon health, inc. (AGL) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.9 billion and a net loss of $391.3 million. Free cash flow was -$119.0 million. As of Sep 30, 2026 it held $174.4 million in cash and investments and $33.4 million in total debt.
Revenue (TTM)
$6.00B
+2.0% vs year-ago TTM
Net income (TTM)
$-87.10M
+71.7% vs year-ago TTM
Operating cash flow (TTM)
$-4.23M
+93.8% vs year-ago TTM
Free cash flow (TTM)
$-17.01M
+79.3% vs year-ago TTM
EPS (TTM)
$-0.21
+92.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
414.87M
+0.6% vs prior year
Net cash
$140.97M
as of Sep 30, 2026
Operating margin
-2.6%
FY 2026
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- AGL (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westerville, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1831097
- Former names
- Agilon Health Topco, Inc. (until Feb 10, 2021)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.9B | $6.1B | $4.3B | $2.4B | $1.5B |
| Operating income | -$463.2M | -$292.1M | -$232.1M | -$105.4M | -$372.2M |
| Net income | -$391.3M | -$260.2M | -$262.6M | -$106.6M | -$406.5M |
| Operating cash flow | -$105.8M | -$57.8M | -$156.2M | -$130.8M | -$148.2M |
| Free cash flow | -$119.0M | -$71.0M | -$172.0M | -$146.2M | -$154.7M |
| Total assets | $1.3B | $1.7B | $1.7B | $1.7B | $1.6B |
| Total liabilities | $1.1B | $1.3B | $1.1B | $656.9M | $494.7M |
| Stockholders' equity | $126.7M | $471.0M | $661.0M | $1.0B | $1.1B |
| Cash and investments | $173.7M | $188.2M | $107.6M | $877.2M | $1.0B |
| Total debt | $36.8M | $44.0M | $52.3M | $56.3M | $60.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
All 432 agilon health, inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.